DKK 135.6
(7.45%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 11.33 Billion DKK | -25.72% |
2022 | 15.26 Billion DKK | 184.86% |
2021 | 5.35 Billion DKK | 27.63% |
2020 | 4.19 Billion DKK | -20.84% |
2019 | 5.3 Billion DKK | 63.98% |
2018 | 3.23 Billion DKK | 6.56% |
2017 | 3.03 Billion DKK | -10.84% |
2016 | 3.4 Billion DKK | 53.89% |
2015 | 2.21 Billion DKK | 35.62% |
2014 | 1.63 Billion DKK | 46.54% |
2013 | 1.11 Billion DKK | 383.91% |
2012 | 230 Million DKK | -81.88% |
2011 | 1.26 Billion DKK | 32.19% |
2010 | 960 Million DKK | -6.71% |
2009 | 1.02 Billion DKK | -35.45% |
2008 | 1.59 Billion DKK | 5.01% |
2007 | 1.51 Billion DKK | 16.32% |
2006 | 1.3 Billion DKK | 80.25% |
2005 | 724 Million DKK | 190.76% |
2004 | 249 Million DKK | -68.44% |
2003 | 789 Million DKK | -36.93% |
2002 | 1.25 Billion DKK | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 11.31 Billion DKK | -0.4% |
2024 Q1 | 11.36 Billion DKK | 0.24% |
2023 Q4 | 11.33 Billion DKK | -6.45% |
2023 Q2 | 12.83 Billion DKK | -19.77% |
2023 FY | 11.33 Billion DKK | -25.72% |
2023 Q1 | 15.99 Billion DKK | 4.8% |
2023 Q3 | 12.11 Billion DKK | -5.56% |
2022 Q2 | 14.96 Billion DKK | 5.19% |
2022 FY | 15.26 Billion DKK | 184.86% |
2022 Q3 | 15.24 Billion DKK | 1.84% |
2022 Q4 | 15.26 Billion DKK | 0.14% |
2022 Q1 | 14.22 Billion DKK | 165.53% |
2021 Q3 | 4.63 Billion DKK | 5.2% |
2021 Q2 | 4.4 Billion DKK | 1.71% |
2021 Q1 | 4.33 Billion DKK | 3.24% |
2021 FY | 5.35 Billion DKK | 27.63% |
2021 Q4 | 5.35 Billion DKK | 15.55% |
2020 Q3 | 5.1 Billion DKK | -8.36% |
2020 Q1 | 6.06 Billion DKK | 14.33% |
2020 FY | 4.19 Billion DKK | -20.84% |
2020 Q2 | 5.57 Billion DKK | -8.11% |
2020 Q4 | 4.19 Billion DKK | -17.77% |
2019 Q1 | 5.16 Billion DKK | 59.62% |
2019 FY | 5.3 Billion DKK | 63.98% |
2019 Q4 | 5.3 Billion DKK | 1.11% |
2019 Q3 | 5.24 Billion DKK | -2.47% |
2019 Q2 | 5.37 Billion DKK | 4.18% |
2018 Q2 | 3.39 Billion DKK | -1.08% |
2018 FY | 3.23 Billion DKK | 6.56% |
2018 Q4 | 3.23 Billion DKK | -2.62% |
2018 Q3 | 3.32 Billion DKK | -2.09% |
2018 Q1 | 3.42 Billion DKK | 12.98% |
2017 FY | 3.03 Billion DKK | -10.84% |
2017 Q3 | 3.05 Billion DKK | -3.05% |
2017 Q2 | 3.14 Billion DKK | -5.8% |
2017 Q1 | 3.34 Billion DKK | -1.79% |
2017 Q4 | 3.03 Billion DKK | -0.59% |
2016 Q4 | 3.4 Billion DKK | 12.45% |
2016 Q1 | 2.73 Billion DKK | 23.78% |
2016 FY | 3.4 Billion DKK | 53.89% |
2016 Q2 | 2.61 Billion DKK | -4.49% |
2016 Q3 | 3.02 Billion DKK | 15.76% |
2015 Q3 | 2.25 Billion DKK | 2.5% |
2015 Q1 | 2.31 Billion DKK | 42.18% |
2015 Q2 | 2.2 Billion DKK | -5.09% |
2015 Q4 | 2.21 Billion DKK | -1.95% |
2015 FY | 2.21 Billion DKK | 35.62% |
2014 Q2 | 1.54 Billion DKK | -4.34% |
2014 Q4 | 1.63 Billion DKK | 0.18% |
2014 Q3 | 1.62 Billion DKK | 5.44% |
2014 FY | 1.63 Billion DKK | 46.54% |
2014 Q1 | 1.61 Billion DKK | 45.01% |
2013 Q3 | 1.01 Billion DKK | 17.95% |
2013 Q4 | 1.11 Billion DKK | 9.98% |
2013 FY | 1.11 Billion DKK | 383.91% |
2013 Q1 | 777 Million DKK | 237.83% |
2013 Q2 | 858 Million DKK | 10.42% |
2012 Q2 | -562 Million DKK | 48.01% |
2012 Q1 | -1.08 Billion DKK | -185.19% |
2012 FY | 230 Million DKK | -81.88% |
2012 Q4 | 230 Million DKK | 173.48% |
2012 Q3 | -313 Million DKK | 44.31% |
2011 Q1 | 1.12 Billion DKK | 17.4% |
2011 FY | 1.26 Billion DKK | 32.19% |
2011 Q4 | 1.26 Billion DKK | 9.97% |
2011 Q2 | 1.06 Billion DKK | -5.59% |
2011 Q3 | 1.15 Billion DKK | 8.46% |
2010 Q2 | 1.01 Billion DKK | 2.74% |
2010 FY | 960 Million DKK | -6.71% |
2010 Q1 | 987 Million DKK | -4.08% |
2010 Q3 | 994 Million DKK | -1.97% |
2010 Q4 | 960 Million DKK | -3.42% |
2009 Q4 | 1.02 Billion DKK | 0.0% |
2009 FY | 1.02 Billion DKK | -35.45% |
2008 FY | 1.59 Billion DKK | 5.01% |
2007 FY | 1.51 Billion DKK | 16.32% |
2006 FY | 1.3 Billion DKK | 80.25% |
2005 FY | 724 Million DKK | 190.76% |
2004 FY | 249 Million DKK | -68.44% |
2003 FY | 789 Million DKK | -36.93% |
2002 FY | 1.25 Billion DKK | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Ambu A/S | 427 Million DKK | -2555.035% |
ChemoMetec A/S | -291.99 Million DKK | 3982.654% |
Demant A/S | 13.31 Billion DKK | 14.862% |
Scandinavian Medical Solutions A/S | 20.68 Million DKK | -54707.034% |
ViroGates A/S | -10.72 Million DKK | 105786.585% |